182 related articles for article (PubMed ID: 8236347)
1. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
Sereghy T; Overgaard K; Boysen G
Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
Overgaard K; Sereghy T; Pedersen H; Boysen G
Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
[TBL] [Abstract][Full Text] [Related]
3. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
Overgaard K; Sereghy T; Pedersen H; Boysen G
J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
Meden P; Overgaard K; Sereghy T; Boysen G
J Neurol Sci; 1993 Nov; 119(2):209-16. PubMed ID: 8277337
[TBL] [Abstract][Full Text] [Related]
5. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
[TBL] [Abstract][Full Text] [Related]
6. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.
Andersen M; Overgaard K; Meden P; Boysen G; Choi SC
Stroke; 1999 Jul; 30(7):1464-71. PubMed ID: 10390324
[TBL] [Abstract][Full Text] [Related]
7. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model.
Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
Stroke; 1992 Aug; 23(8):1167-73; discussion 1174. PubMed ID: 1636193
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.
Sakurama T; Kitamura R; Kaneko M
Stroke; 1994 Feb; 25(2):451-6. PubMed ID: 8303756
[TBL] [Abstract][Full Text] [Related]
9. Effect of hypothermia and delayed thrombolysis in a rat embolic stroke model.
Meden P; Overgaard K; Pedersen H; Boysen G
Acta Neurol Scand; 1994 Aug; 90(2):91-8. PubMed ID: 7801745
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
[TBL] [Abstract][Full Text] [Related]
12. The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model.
Meden P; Overgaard K; Pedersen H; Boysen G
Brain Res; 1994 May; 647(1):131-8. PubMed ID: 8069695
[TBL] [Abstract][Full Text] [Related]
13. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke.
Gross CE; Raymond SJ; Howard DB; Bednar MM
Neurosurgery; 1995 Jun; 36(6):1172-7. PubMed ID: 7643999
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
[TBL] [Abstract][Full Text] [Related]
15. Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model.
Overgaard K; Sereghy T; Pedersen H; Boysen G
Neuroreport; 1992 Oct; 3(10):925-8. PubMed ID: 1421100
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
[TBL] [Abstract][Full Text] [Related]
17. A new rat model of thrombotic focal cerebral ischemia.
Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
[TBL] [Abstract][Full Text] [Related]
18. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
Zhang RL; Chopp M; Zhang ZG; Divine G
J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
[TBL] [Abstract][Full Text] [Related]
19. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
Zhang L; Zhang ZG; Zhang RL; Lu M; Adams J; Elliott PJ; Chopp M
Stroke; 2001 Dec; 32(12):2926-31. PubMed ID: 11739997
[TBL] [Abstract][Full Text] [Related]
20. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.
Hamilton MG; Lee JS; Cummings PJ; Zabramski JM
Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
